CLINICAL_TRIALS
trial_result
· 2021-04-08
Clinical Trial Update: RCT (Randomized Control Trial) of TD139 vs Placebo in HV's (Human Volunteers) and IPF Patients [Phase 1, Phase 2]
Summary
The study reports completed Phase 1/Phase 2 results for TD139 versus placebo in idiopathic pulmonary fibrosis patients, with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Galecto Biotech AB | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-04-08